Understanding how T cells develop and function in cancer treatment
Transcriptional and metabolic heterogeneity in T cell differentiation
This study is looking at how T cells, which help fight cancer, can be made even better at attacking tumors, so that new treatments can work more effectively for patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | St. Jude Children's Research Hospital NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project ID | NIH-11112552 on NIH RePORTER |
What this research studies
This research investigates the different ways T cells, which are crucial for fighting cancer, develop and function. It focuses on understanding the unique characteristics of these cells and how they can be improved to enhance their effectiveness in cancer therapies. By using advanced techniques like single-cell CRISPR screens, the researchers aim to identify key factors that influence T cell differentiation and metabolism, which could lead to better immunotherapy outcomes for patients. The goal is to find ways to reprogram T cells to improve their ability to attack tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancer who are undergoing or considering immunotherapy treatments.
Not a fit: Patients with non-cancerous conditions or those not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer immunotherapies that improve patient outcomes.
How similar studies have performed: Other research has shown promising results in enhancing T cell function through similar approaches, indicating potential for success in this area.
Where this research is happening
Memphis, United States
- St. Jude Children's Research Hospital — Memphis, United States (Active)
Researchers
- Principal investigator: Chi, Hongbo — St. Jude Children's Research Hospital
- Study coordinator: Chi, Hongbo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.